Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

How effective is alcoholism treatment in the United States?

Miller WR, Walters ST, Bennett ME.

J Stud Alcohol. 2001 Mar;62(2):211-20. Review.

PMID:
11327187
2.

Outcome variables and their assessment in alcohol treatment studies: 1968-1998.

Finney JW, Moyer A, Swearingen CE.

Alcohol Clin Exp Res. 2003 Oct;27(10):1671-9. Review.

PMID:
14574240
3.

Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.

Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D; Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology; Technology Assessment Committee of the Society of Interventional Radiology.

Stroke. 2003 Aug;34(8):e109-37. Epub 2003 Jul 17. Erratum in: Stroke. 2003 Nov;34(11):2774.

4.

Clinical and methodological utility of a composite outcome measure for alcohol treatment research.

Zweben A, Cisler RA.

Alcohol Clin Exp Res. 2003 Oct;27(10):1680-5. Review.

PMID:
14574241
5.
6.

Moderate drinking in the first year after treatment as a predictor of three-year outcomes.

Maisto SA, Clifford PR, Stout RL, Davis CM.

J Stud Alcohol Drugs. 2007 May;68(3):419-27. Erratum in: J Stud Alcohol Drugs. 2008 Jul;69(4):622.

PMID:
17446982
7.

[Meta-analysis of the Italian studies on short-term effects of air pollution].

Biggeri A, Bellini P, Terracini B; Italian MISA Group.

Epidemiol Prev. 2001 Mar-Apr;25(2 Suppl):1-71. Italian.

PMID:
11515188
8.

Effectiveness of naltrexone in a community treatment program.

Killeen TK, Brady KT, Gold PB, Simpson KN, Faldowski RA, Tyson C, Anton RF.

Alcohol Clin Exp Res. 2004 Nov;28(11):1710-7.

PMID:
15547458
9.

Alcohol use outcomes and heavy drinking at 4-5 years among a treatment sample of drug misusers.

Gossop M, Browne N, Stewart D, Marsden J.

J Subst Abuse Treat. 2003 Oct;25(3):135-43.

PMID:
14670519
10.

Treatment for alcohol dependence in Catalonia: health outcomes and stability of drinking patterns over 20 years in 850 patients.

Gual A, Bravo F, LligoƱa A, Colom J.

Alcohol Alcohol. 2009 Jul-Aug;44(4):409-15. doi: 10.1093/alcalc/agp032. Epub 2009 Jun 2.

12.

Two-year outcome of an intervention program for university students who have parents with alcohol problems: a randomized controlled trial.

Hansson H, Rundberg J, Zetterlind U, Johnsson KO, Berglund M.

Alcohol Clin Exp Res. 2007 Nov;31(11):1927-33. Epub 2007 Sep 26.

PMID:
17908264
13.

Alcohol consumption as a risk factor for non-recovery from common mental disorder: results from the longitudinal follow-up of the National Psychiatric Morbidity Survey.

Haynes JC, Farrell M, Singleton N, Meltzer H, Araya R, Lewis G, Wiles NJ.

Psychol Med. 2008 Mar;38(3):451-5. Epub 2007 Nov 1.

PMID:
17977480
14.

Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force report.

Coons SJ, Gwaltney CJ, Hays RD, Lundy JJ, Sloan JA, Revicki DA, Lenderking WR, Cella D, Basch E; ISPOR ePRO Task Force.

Value Health. 2009 Jun;12(4):419-29. doi: 10.1111/j.1524-4733.2008.00470.x. Epub 2008 Nov 11.

PMID:
19900250
15.

Outpatient alcoholism treatment: predictors of outcome after 3 years.

Bottlender M, Soyka M.

Drug Alcohol Depend. 2005 Oct 1;80(1):83-9.

PMID:
15878808
16.

Are alcoholism treatments effective? The Project MATCH data.

Cutler RB, Fishbain DA.

BMC Public Health. 2005 Jul 14;5:75.

17.

Does Cryotherapy Improve Outcomes With Soft Tissue Injury?

Hubbard TJ, Denegar CR.

J Athl Train. 2004 Sep;39(3):278-279.

18.

Understanding results from randomized trials: use of program- and client-level data to study medical and nonmedical treatment programs.

Kaskutas LA, Ammon L, Witbrodt J, Graves K, Zemore S, Borkman T, Weisner S.

J Stud Alcohol. 2005 Sep;66(5):682-7.

PMID:
16331853
19.

The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease.

Loveman E, Green C, Kirby J, Takeda A, Picot J, Payne E, Clegg A.

Health Technol Assess. 2006 Jan;10(1):iii-iv, ix-xi, 1-160. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk